Epidermal growth factor receptor expression in cervical intraepithelial neoplasia and its modulation during an α-difluoromethylornithine chemoprevention trial

Clinical Cancer Research

Volumn 4, Issue 6, 1998, Pages 1383-1391

  Boiko, Iouri V ^a   Mitchell, Michele Follen ^a   Hu, Wei ^a   Pandey, Dilip K ^a   Mathevet, Patrice ^a   Malpica, Anais ^a   Hittelman, Walter N ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EFLORNITHINE; EPIDERMAL GROWTH FACTOR RECEPTOR; ORNITHINE DECARBOXYLASE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER INVASION; DOSE RESPONSE; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMAGE ANALYSIS; LIGAND BINDING; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; TUMOR GROWTH; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU;

ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; DISEASE PROGRESSION; EFLORNITHINE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 0031779550     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Bornstein, J., Rahat, M. A., and Abramovici, H. Etiology of cervical cancer: current concepts. Obstet. Gynecol. Surv., 50: 146-154, 1995.
2. Mitchell, M. F., Hittelman, W. N., Lotan, R., Nishioka, K., Tortolero-Luna, G., Richards-Kortum, R., Wharton, J. T., and Hong, W. K. Chemoprevention trials and surrogate end point biomarkers in the cervix. Cancer (Phila.), 76 (Suppl.): 1956-1977, 1995.
3. Hanselaar, A. G., Vooijs, G. P., Mayall, B. H., Pahlplatz, M. M., and Van't Hof-Grootenboer, A. E. DNA changes in progressive cervical intraepithelial neoplasia. Anal. Cell. Pathol., 4: 315-324, 1992.
4. Mitchell, M. F., Hittelman, W. N., Hong, W. K., Lotan, R., and Schottenfeld, D. The natural history of cervical intraepithelial neoplasia: an argument for intermediate endpoint biomarkers. Cancer Epidemiol. Biomark. Prev., 3: 619-626, 1994.
5. Earp, H. S., Dawson, T. L., Li, X., and Yu, H. Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research. Breast Cancer Res. Treat., 35: 115-132, 1995.
6. Khazaie, K., Schirrmacher, V., and Lichtner, R. B. EGF receptor in neoplasia and metastasis. Cancer Metastasis Rev., 12: 255-274, 1993.
7. Eppenberger, U., and Mueller, H. Growth factor receptors and their ligands. J. Neuro-oncol., 22: 249-254, 1994.
8. Chen, P., Xie, H., and Wells, A. Mitogenic signaling from the EGF receptor is attenuated by a phospholipase C-γ/protein kinase C feedback mechanism. Mol. Biol. Cell, 7: 871-881, 1996.
9. Daub, H., Weiss, F. U., Wallasch, C., and Ullrich, A. Role of transactivation of the EGF receptor in signaling by G-protein-coupled receptors. Nature (Lond.), 379: 557-560, 1996.
10. Hu, Y. L., and Bowtell, D. D. L. S0S1 rapidly associates with GRB2 and is hypophosphorylated when complexed with the EGF receptor after EGF stimulation. Oncogene, 12: 1864-1872, 1996.
11. Shin, D. M., Ro, J. Y., Hong, W. K., and Hittelman, W. N. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. Cancer Res., 54: 3153-3159, 1994.
12. Pfeiffer, D., Stellwag, B., Pfeifer, A., Borlinghaus, P., Meier, W., and Scheidel, P. Clinical implications of the epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervix. Gynecol. Oncol., 33: 146-150, 1989.
13. Maruo, T., Yamasaki, M., Ladines-Llave, C. A., and Mochizuki, M. Immunohistochemical demonstration of elevated expression of epidermal growth factor receptor in the neoplastic changes of cervical squamous epithelium. Cancer (Phila.), 69: 1182-1187, 1992.
14. Goppinger, A., Wittmaack, F. M., Wintzer, H. O., Ikenberg, H., and Bauknecht, T. Localization of human epidermal growth factor receptor in cervical intraepithelial neoplasias. J. Cancer Res. Clin. Oncol., 115: 259-263, 1989.
15. Mittal, K., Pearson, J., and Demopoulos, R. Patterns of mRNA for epidermal growth factor receptor and keratin B-2 in normal cervical epithelium and in cervical intraepithelial neoplasia. Gynecol. Oncol., 38: 224-229, 1990.
16. Wistuba, I., Roa, I., Araya, J., Villaseca, M., Chavez, F., and Capurro, I. Immunohistochemical expression of epidermal growth factor receptor (EGFR) in epidermoid carcinoma of the cervix uteri and its precursor lesions. Rev. Chil. Obstet. Ginecol., 59: 116-122, 1994.
17. Kelloff, G. J., Boone, C. W., Steele, V. E., Fay, J. R., Lubet, R. A., Crowell, J. A., and Sigman, C. C. Mechanistic considerations in chemopreventive drug development. J. Cell. Biochem. Suppl., 20: 1-24, 1994.
18. Marton, L. J., and Pegg, A. E. Polyamines as targets for therapeutic intervention. Annu. Rev. Pharmacol. Toxicol., 35: 55-91, 1995.
19. Pegg, A. E., Shantz, L. M., and Coleman, C. S. Ornithine decarboxylase as a target for chemoprevention. J. Cell. Biochem. Suppl., 22: 132-138, 1995.
20. Auvinen, M., Paasinen, A., Andersson, L. C., and Holtta, E. Ornithine decarboxylase activity is critical for cell transformation. Nature (Lond.), 360: 355-358, 1992.
21. Nishioka, K., Melgarejo, A. B., Lyon, R. R., and Mitchell, M. F. Polyamines as biomarkers of cervical intraepithelial neoplasia. J. Cell. Biochem. Suppl., 23: 87-95, 1995.
22. Boiko, I. V., Mitchell, M. F., Pandey, D. K., White, R. A., Hu, W., Malpica, A., Nishioka, K., Boone, C. W., Palcic, B., and Hittelman, W. N. DNA image cytometric measurement as a surrogate endpoint biomarker (SEB) in a phase I trial of α-difluoromethylornithine for cervical intraepithelial neoplasia. Cancer Epidemiol. Biomark. Prev., 6: 849-855, 1997.
23. Scully, R. E., Bonfigio, T. A., Kurman, R. J., Silverberg, S. G., and Wilkinson, E. J. Histological Typing of Female Genital Tract Tumours, Ed. 2, p. 189. Berlin, New York: Springer-Verlag, 1994.
24. Mitchell, M. F., Tortolero-Luna, G., Lee, J. J., Hittelman, W. N., Lotan, R., Wharton, J. T., Hong, W. K., and Nishioka, K. Phase I dose de-escalation trial of I-difluoromethylornithine in patients with grade 3 cervical intraepithelial neoplasia. Clin. Cancer Res., 4: 303-310, 1998.
25. Martin, P., Vass, W. C., Schiller, J. T., Lowy, D. R., and Velu, T. J. The bovine papillomavirus E5 transforming protein can stimulate the transforming activity of EGF and CSF-1 receptors. Cell, 59: 21-32, 1989.
26. Formento, J. L., Francoual, M., Ramaioli, A., Dassonville, O., Santini, J., Demard, F., Schneider, M., and Milano, G. EGF receptor, a prognostic factor in epidermoid cancers of the upper aerodigestive tracts [in French]. Bull, du Cancer, 81: 610-615, 1994.
27. Hickey, K., Grehan, D., Reid, I. M., O'Briain, S., Walsh, T. N., and Hennessy, T. P. Expression of epidermal growth factor receptor and proliferating cell nuclear antigen predicts response of esophageal squamous cell carcinoma to chemoradiotherapy. Cancer (Phila.), 74: 1693-1698, 1994.
28. Fabian, C. J., Zalles, C., Kamel, S., Kimler, B. F., McKittrick, R., Tranin, A. S., Zeiger, S., Moore, W. P., Hassanein, R. S., Simon, C., Johnson, N., Vergara, G., Jewell, W. R., Lin, F., Bhatia, P., and Chin, T. Prevalence of aneuploidy, overexpressed ER, and overexpressed EGFR in random breast aspirates of women at high and low risk for breast cancer. Breast Cancer Res. Treat., 30: 263-274, 1994.
29. Hu, W., Mitchell, M. F., Boiko, I. V., Linares, A., Kim, H. G., Malpica, A., Tortolero-Luna, G., and Hittelman, W. N. Progressive dysregulation of proliferation during cervical carcinogenesis as measured by MPM-2 antibody staining. Cancer Epidemiol. Biomark. Prev., 6: 711-718, 1997.
30. Hu, W., Mitchell, M. F., Boiko, I. V., Malpica, A., Linares, A., and Hittelman, W. N. Decreased PCNA expression in cervical premalignant lesions after chemoprevention by α-difluoromethylornithine (DFMO). Proc. Am. Assoc. Cancer Res. Annu. Meet., 37: A1265, 1996.
31. Moshier, J. A., Malecka-Panas, E., Geng, H., Dosescu, J., Tureaud, J., Skunca, M., and Majumdar, A. P. Ornithine decarboxylase transformation of NIH/3T3 cells is mediated by altered epidermal growth factor receptor activity. Cancer Res., 55: 5358-5365, 1995.
32. Auvinen, M., Laine, A., Paasinen-Sohns, A., Kangas, A., Kangas, L., Saksela, O., Andersson, L. C., and Holtta, E. Human ornithine decarboxylase-overproducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice. Cancer Res., 57: 3016-3025, 1997.
33. Brzozowski, T., Konturek, S. J., Majka, J., Dembinski, A., and Drozdowicz, D. Epidermal growth factor, polyamines, and prostaglandins in healing of stress-induced gastric lesions in rats. Dig. Dis. Sci., 38: 276-283, 1993.
34. Wang, J. Y., and Johnson, L. R. Expression of protooncogenes c-fos and c-myc in healing of gastric mucosal stress ulcers. Am. J. Physiol., 266: G878-886, 1994.
35. Lippman, S. M., Shin, D. M., Lee, J. J., Batsakia, J. G., Lotan, R., Tainsky, M. A., Hittelman, W. N., and Hong, W. K. p53 and retinoid chemoprevention of oral carcinogenesis. Cancer Res., 55: 16-19, 1995.
36. Papadimitrakopoulou, V. A., Shin, D. M., Clayman, G., El-Naggar, A., Shin, H. J., Lippman, S. M., Martinez, L., Gillenwater, A., Callender, D., Goepfert, H., and Hong, W. K. Efficacy of biochemoprevention in reversal of advanced premalignant lesions in the upper aerodigestive tract. Proc. Am. Soc. Clin. Oncol. Annu. Meet., 16: 1366, 1997.
37. Rusch, V., Mendelsohn, J., and Dmitrovsky, E. The epidermal growth factor receptor and its ligands as therapeutic targets in human tumors. Cytokine Growth Factor Rev., 7: 133-141, 1996.
38. Korutla, L., Cheung, J. Y., Mendelsohn, J., and Kumar, R. Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by curcumin. Carcinogenesis (Lond.), 16: 1741-1745, 1995.